ROLE OF POTASSIUM CHANNELS IN FRIBRILLATORY CONDUCTION
钾通道在颤动传导中的作用
基本信息
- 批准号:7496152
- 负责人:
- 金额:$ 37.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-13 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementArrhythmiaBiochemicalCalciumCardiacCaviaCell CommunicationCellsCellular biologyCollaborationsCommunicationComputer softwareConditionDailyElectronicsFailureFrequenciesGap JunctionsGene MutationGene TransferGenotypeHeartHeart AtriumHeterogeneityIndividualInfarctionInvestigationIon ChannelIsoproterenolKineticsKir2.1 channelLeadLinkMapsMediatingMinkModificationMolecularMolecular BiologyMusMuscleMuscle CellsMutagenesisMutationMyocardial IschemiaOpticsPatientsPlayPotassiumPotassium ChannelProductionProtein OverexpressionProteinsProtocols documentationRateRattusRecoveryRegulationResearch PersonnelResourcesRoleServicesSheepSodiumStructureSympathetic Nervous SystemSyndromeTachyarrhythmiasTestingTimeTransgenesTransgenic MiceTransgenic OrganismsVentricularViralVirusWorkdensitygain of functiongain of function mutationgenetic manipulationhuman studyinsightmonolayermouse genomemutantpatch clampprogramsresponsesimulationtooltwo-dimensional
项目摘要
This project is aimed at increasing the understanding of the role of potassium channels in the control of
frequency dependent cardiac excitation, intermittent wave propagation and fibril latory conduction. We
propose a multi-disciplinary approach to investigate the individual and cooperative roles in normal and
abnormal excitability played by the strong inward rectifier Kir2.1 (KCNJ2) channel that is responsible
for IK1 and the delayed rectifiers HERG (KCNH2) and KvLQT1(KCNQ1;/minK(KCNE1) forming the
channels that carry IKr and IKs, respectively. Our main focus is the manner in which the degree of
inward rectification of lK1 and the gating kinetics of IKrand IKs alone or in combination, modify the ability
of cardiac electrical waves to propagate when interacting with anatomical or functional obstacles in
their path. Our general hypothesis is that changes in the density of IK1, lKr and/or lK have sharp
consequences on excitability and conduction, and thus on the dynamics of spatially distributed,
intermittent wavelets that propagate through atrial and ventricular muscle during fibrillation. Our
approaches span three different levels of integration: the cell, the two-dimensional myocyte monolayer
and the three-dimensional heart. At the cellular level (Specific Aim 1), we take advantage of the tools of
molecular biology, viral transfer and patch clamping to test unambiguously the idea that, in the
presence of unchanged excitatory sodium and/or calcium currents, post-repolarization refractoriness
and rate-dependent excitation are controlled by both the degree IK1 rectification and the kinetics of IKr and/or IKs gating. At the two-dimensional level (Specific Aim 2), we investigate and quantify the
individual roles of these three different currents in wavebreak formation and the phenomenon of
"vortex shedding". Finally, at the level of the whole heart (Specific Aim 3), we use a transgenic
approach and optical mapping to investigate the electrophysiological consequences of genetic
mutations in Kir channels leading to greater outward IK1 density; and the effects of introducing IKs into
the mouse genome on the dynamics of rotors and VF and their modification by autonomic input.
Successful achievement of our objectives should help clarify the molecular mechanisms of wavebreak
in cardiac fibrillation. The work proposed is directly relevant to the understanding of the pro-arrhythmic
effects of gain-of-function changes in specific potassium channels that have been shown to occur in
certain clinically conditions, including persistent AF, the short QT syndrome and idiopathic VF.
该项目旨在增加对钾通道在控制
频率依赖性心脏兴奋、间歇性波传播和纤维性传导。我们
提出了一个多学科的方法来调查个人和合作的作用,在正常和
由负责的强内向整流Kir2.1(KCNJ2)通道发挥的异常兴奋性
对于IK1和延迟整流器HERG(KCNH2)和KvLQT1(KCNQ1;/minK(KCNE1),
分别携带IKr和IKs的通道。我们主要关注的是,
IK1的内向整流和IKrandIKs的门控动力学单独或组合,
当与解剖或功能障碍物相互作用时,
我们的一般假设是,IK1,lKr和/或lK密度的变化具有明显的
对兴奋性和传导的影响,从而对空间分布的动力学,
在纤维性颤动期间通过心房和心室肌传播的间歇性小波。我们
方法跨越三个不同层次的整合:细胞,二维肌细胞单层,
和三维心脏。在细胞水平(具体目标1),我们利用以下工具:
分子生物学、病毒转移和膜片钳技术来明确地测试这种想法,
存在不变的兴奋性钠和/或钙电流,复极后不应性
和速率依赖性兴奋的程度IK1整流和IKr和/或IKs门控的动力学控制。在二维水平(具体目标2),我们调查和量化
这三种不同的电流在波浪破碎形成和现象的个别作用
"旋涡脱落"。最后,在整个心脏的水平上(具体目标3),我们使用转基因的
方法和光学作图来研究遗传性的电生理后果
Kir通道的突变导致更大的外向IK1密度;以及将IKs引入
小鼠基因组的动态转子和VF和他们的修改自主输入。
我们的目标的成功实现将有助于阐明波裂的分子机制
心脏纤维性颤动所提出的工作直接关系到对亲生物学的理解。
已经证明发生在特定钾通道中的功能获得性变化的影响,
某些临床状况,包括持续性房颤、短QT综合征和特发性VF。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jose S Jalife其他文献
Jose S Jalife的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jose S Jalife', 18)}}的其他基金
Peptibodies As Novel Therapies in Atrial Fibrillation
肽体作为心房颤动的新疗法
- 批准号:
10598711 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
Training Program in Translational Cardiovascular Research and Entrepreneurship
转化心血管研究和创业培训计划
- 批准号:
9035429 - 财政年份:2015
- 资助金额:
$ 37.17万 - 项目类别:
Training Program in Translational Cardiovascular Research and Entrepreneurship
转化心血管研究和创业培训计划
- 批准号:
9293359 - 财政年份:2015
- 资助金额:
$ 37.17万 - 项目类别:
Training Program in Translational Cardiovascular Research and Entrepreneurship
转化心血管研究和创业培训计划
- 批准号:
8935389 - 财政年份:2015
- 资助金额:
$ 37.17万 - 项目类别:
Intermolecular Interactions of NaV1.5 and Kir2.1 In Ion Channel Diseases
NaV1.5 和 Kir2.1 在离子通道疾病中的分子间相互作用
- 批准号:
8816386 - 财政年份:2014
- 资助金额:
$ 37.17万 - 项目类别:
Intermolecular Interactions of NaV1.5 and Kir2.1 In Ion Channel Diseases
NaV1.5 和 Kir2.1 在离子通道疾病中的分子间相互作用
- 批准号:
9173051 - 财政年份:2014
- 资助金额:
$ 37.17万 - 项目类别:
ROLE OF POTASSIUM CHANNELS IN FRIBRILLATORY CONDUCTION
钾通道在颤动传导中的作用
- 批准号:
7921514 - 财政年份:2009
- 资助金额:
$ 37.17万 - 项目类别:
Arrhythmia Mechanisms in Two Inherited Cardiac Diseases
两种遗传性心脏病的心律失常机制
- 批准号:
8122110 - 财政年份:2007
- 资助金额:
$ 37.17万 - 项目类别:
Arrhythmia Mechanisms in Two Inherited Cardiac Diseases
两种遗传性心脏病的心律失常机制
- 批准号:
7690851 - 财政年份:2007
- 资助金额:
$ 37.17万 - 项目类别:
Arrhythmia Mechanisms in Two Inherited Cardiac Diseases
两种遗传性心脏病的心律失常机制
- 批准号:
7928105 - 财政年份:2007
- 资助金额:
$ 37.17万 - 项目类别:
相似海外基金
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
- 批准号:
10668025 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
- 批准号:
514892030 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
WBP Fellowship
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
- 批准号:
23K09597 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
- 批准号:
10638497 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:
10727929 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别: